Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Quite the spread on GARB!
PASO .0155 off and running!
PRB something big is cooking, look at the last few days. They are expecting this well over a dollar, Chromite is where its at!!!
PSGI news just out>>>> Prime Star Group's Wild Grill Foods, Inc. Receives 1 Million Dollar Factoring Line of Credit
2010-08-13 10:30 ET - News Release
LAS VEGAS, NV -- (MARKET WIRE) -- 08/13/10
Prime Star Group, Inc. (PINKSHEETS: PSGI) is pleased to announce Wild Grill Foods, Inc., a Prime Star Group wholly owned subsidiary, has received a One Million Dollar ($1,000,000.00) factoring line of credit from JD Factors.
Wild Grill Foods, Inc's President, Jerry Luderman, stated, "We are very pleased to be doing business with JD Factors and are excited to continue to make the Wild Grill family of products accessible to every consumer through national and regional retailers. JD Factors is an excellent company with an outstanding reputation. We are extremely excited to be doing business with their dynamic team. Wild Grill remains focused on manufacturing high quality seafood that tastes great at an affordable price point. This agreement ensures that we can meet the needs of our customers and continue with our operational growth. We have finished our research and development on our highly anticipated Gourmet Seafood Sliders and have shipped samples to all of our biggest customers. We have had tremendous response."
Prime Star Group's CEO, Roger Mohlman, added, "Prime Star Group is thrilled at the growth of Wild Grill and we are committed to the continued expansion of the business unit."
Where you off to?
Any major announcements from LDSR coming up since their reporting of revenues?
HLCS recently has had some nice activity!
SNMN sweet looking!
That BEIJING BILL knows how to pick'em!!!
Briboy...there's a whole world out there to see and experience!!!!
Will do, thanks!
Watch the sellers to show up....like McDonalds workers pushing the "sell botton"!
You don't want to be face-slapped with those :)
LOL...used to hold them in my hands!
SIRG? You mean GPGD +222%!!!!!!
Is ATWT going to go?
TMTP .0016 x .0018
GLER putting up a good fight taking down the offers!
NPDT looking to break here at the open!
Where the heck you been?
News this morning should make her pop!
GLER news out: Global Earth Energy, Inc. Installs First Solar Car Wash System With Skogies Car Washes of Canada
2010-08-04 09:00 ET - News Release
WILMINGTON, NC -- (MARKET WIRE) -- 08/04/10
Global Earth Energy, Inc. (OTCBB: GLER) announced today that its subsidiary, RCI Solar, has installed its first solar car wash system at Skogies Car Washes of British Columbia, Canada.
Simple ideas can make a big difference -- for example, to increase the efficiency of each car wash, by using the energy from the sun, Skogies has increased the water temperature during the soap cycle to better clean each vehicle as it passes through. Not only does it reduce the amount of water required but it also reduces the amount of chemicals necessary for a "clean" vehicle. Naturally this also reduces the amount of energy to maintain the water at a prefect operating temperature. This simple solution saves big dollars in operating cost for Skogies, up to 60% in hot heating costs alone! With average operating costs of over $10,000 per month during peak months, this system can now account for a true return-on-investment.
There are three major reasons why the installation of these new solar hot water heating system is critical in saving money for Skogies. First, the hot water has a degreasing effect that reduces the use of chemicals by over fifty percent -- the hotter the water the less amount of chemicals required.
Second, the cost to increase the temperature from 40 degrees as supplied from the utility company to an average of 90 to 120 degrees has been sufficiently reduced by a minimum of sixty percent. The solar array maintains an average of 70 degrees on a typical winter day (even when the thermostat falls below zero). During the spring, summer and fall months, the average temperature is much, much higher and the requirements to use the boilers is drastically reduced.
And third, the flow rate per litre, per minute in the solar circuit produces up to fifty percent more hot water per hour, which is enough to wash twice the amount vehicle in the same amount of time. The solar solution does stop there, in Canada the temperatures can be trying during the winter months with freezing conditions reaching an easy (-20) degrees. The solar loop also feeds the radiant floor heating at the entrance and exit of the cars wash bay to prevent ice build up and reduce accidents as well as other liabilities inherent to their business. Can they do more to save money, yes! Phase two will consider using the heat collected to heat their building as well as for hot water in their customer washrooms.
"The Eco-Energy Solar Car Washes solution saves on energy, chemicals and the environment," commented a spokesman for Skogies Car Washes, and we are delighted to be able to integrate the solar car wash system into Skogies.
"Going Green is one of the best operational investments a business can make, turning highly variable energy costs into a low, predictable operating expense, turning former utility expenses into profits," said Syd Harland, CEO of Global Earth Energy, Inc. "We look forward to providing our systems to all Skogies Car Washes in the future."
Nice, CABN could go here!
Sinobiopharma likes to stay in the .26 - .28 range
GCKO (news just released)---> GeckoSystems and Japanese Robot Company Sign Agreement
2010-08-03 09:45 ET - News Release
CONYERS, GA -- (MARKET WIRE) -- 08/03/10
GeckoSystems Intl. Corp. (PINKSHEETS: GCKO) (http://www.geckosystems.com/) -- announced today that their Japanese representative, Hajime Yasumatsu, has successfully negotiated an Memorandum of Understanding (MOU) with a leading Japanese personal robot manufacturer, Business Design Laboratory Co., Ltd. (BDL).
GeckoSystems is a dynamic leader in the emerging mobile robotics industry revolutionizing their development and usage with "Mobile Robot Solutions for Safety, Security and Service(tm)."
"We are pleased to announce the signing of this foundation agreement. The Japanese have their own eldercare crisis because of the size of their WWII widow population. Due to their understanding of the high costs of sufficient and appropriate eldercare, the Japanese government has spent one hundred million dollars ($100,000,000) in grants (to Sanyo, Toshiba, Hitachi, Fujitsu, NEC, etc.) over the last eight to ten years to develop personal robots for their own eldercare crisis, yet only limited solutions have been developed by them to date. Now that we have this initial agreement in place, we can progress forward exploring our many areas of common interest with BDL," commented Martin Spencer, President/CEO, GeckoSystems.
"BDL is in the business to do planning, development, manufacturing and sales of intelligent communication robots. They are aiming for the leading position in the Japanese personal robot industry. BDL will contribute to the 'Aging (Japanese) Society with Fewer Children.' They intend to further growth of a new industry and support venture businesses by coordinating joint projects among industry, government, and education entities.
"BDL's associated companies include the following: Brother Industries, Ltd., (product design), NEC System Technologies, Ltd., (voice recognition and text-to-speech technologies), Asahi Kasei Corporation, (robotics engines), and Futaba Industrial Co., (manufacturing)," observed Hajime Yasumatsu, Chairman, Yasu, Inc.
In this fundamental agreement, the CEO's of both companies agree that "having carefully assessed their mutual interests, have determined that they would benefit from exploring the possibilities on a non exclusive basis of entering into joint collaborations for R&D, market research, technology licensing, distribution and manufacturing in Japan, etc." This would include, but not be limited to, the localization (adaptation) of GeckoSystems' CareBot(tm) for the Japanese marketplace.
"I believe their interest in us is due to not only our flagship product, the automatic self navigation software, GeckoNav(tm), but also the reality that we have a complete multitasking personal assistant robot, the CareBot. We continue to expect technology licensing revenues, primarily software, to precede revenues from product manufacturing and sales. BDL and GeckoSystems are investigating collaborating on the development of a four-degree of freedom (DOF) low cost robot arm appropriate for mobile service robots and light industrial use. BDL has indicated interest in GeckoSystems enabling the US distribution of the jointly designed light industrial version of this initial project and is presently quoting on the cost of this R&D project.
"The cost saving benefits of GeckoSystems' suite of mobile robot technologies will generate multiple revenue streams for GeckoSystems in the form of licensing, royalties, training, and sales of various hardware systems and subsystems. I expect the synergies revealed in our confidential discussions to result in distribution into the Japanese market and enable significant cost reductions in the systems and subsystems we import from Japan. As one would expect, licensing revenues and a more competitive cost structure will increase shareholder value and ROI for our stockholders," opined Spencer.
WTWO .006 x .0064 (2/1) up on news!
ADLS Advanced Life Sciences Applies to IRS for Cash Grant Under the Qualifying Therapeutic Discovery Project
2010-08-03 08:00 ET - News Release
CHICAGO, Aug. 3 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that the Company has applied for a cash grant under the Qualifying Therapeutic Discovery Project which was created by Congress as part of the Patient Protection and Affordable Care Act of 2010. The Company has submitted an application for its development of Restanza™, a novel once-daily oral antibiotic for the treatment of community acquired bacterial pneumonia (CABP).
KATX...thoughts?
You driving an 18 wheeler or Pizza delivery truck? :)
Airlines and Railways...continue to do well!
AAWW Atlas Air Worldwide beats by $0.78, beats on revs; raises FY10 EPS guidance above consensus
Reports Q2 (Jun) earnings of $1.82 per share, excluding non-recurring items, $0.78 better than the Thomson Reuters consensus of $1.04; revenues rose 48.4% year/year to $356.2 mln vs the $311.4 mln consensus. Co raises guidance for FY10, sees EPS of exceed $4.35, excluding non-recurring items, vs. $4.30 Thomson Reuters consensus, up from $4.00 previously. Total block hours increased 22% YoY, while average operating aircraft, excluding Dry Leasing aircraft, declined 2%. Average utilization of operating aircraft, excluding Dry Leasing aircraft, totaled ~12.6 hours per aircraft per day during the quarter compared with 10.1 in the second quarter of 2009, reflecting a substantial increase in flying activity by ACMI and Commercial Charter customers compared with the second quarter of 2009.
NXXI looking pretty!
I thought the maze on Pac-Mac was hard....this one is one cluster f#cK! The German chick on the right, has what in her hands...Honey?
Very nice!
There's a few on the go GL, but a case of beer goes hand in hand during trading hours!
Where's all the GLER supporters?
UDHI 1 left at .0038
GLER .06 HOD bids need to come up!
RPC news, could make for a break over $1:
Radient Pharmaceuticals' China-Based Subsidiary Jade Pharmaceuticals Signs Letter of Intent to Acquire Shanxi Baotai Pharmaceutical Co. Ltd.
2010-07-28 08:45 ET - News Release
TUSTIN, CA -- (MARKET WIRE) -- 07/28/10
Radient Pharmaceuticals Corporation (RPC) (NYSE Amex: RPC) announced today its China-based subsidiary Jade Pharmaceuticals Inc. (JPI) signed a letter of intent (LOI) under which JPI will acquire Shanxi BaoTai Pharmaceutical Co., Ltd. (BaoTai), a privately owned pharmaceutical manufacturing company located in Taiyuan China, through a non-taxable merger of business assets. The transaction, assuming all closing conditions are satisfied or waived, is expected to close in mid-November 2010. The transaction combines the strengths of JPI and BaoTai, two highly successful Chinese pharmaceutical companies, into a single formidable enterprise focused on developing cancer-centric products recognized for quality, branded product names and technical leadership.
Under the non-binding LOI, the companies contemplate completing the transaction as a merger (structured to qualify as a tax-free reorganization). Upon completion of the merger, BaoTai's shareholders will receive shares of JPI common stock based on certain exchange ratios. In the near term, JPI expects to complete a bridge financing to fund expenses associated with the anticipated merger between the combined entities and a public company. After completing the transaction with BaoTai and the bridge financing, JPI intends to complete the merger with the public company; together, they will then seek to list the public shares on the NYSE Amex.
"This acquisition fits well with the monetization strategy for JPI. Through JPI's business development plan, they intend to develop a high-growth business focused on delivering novel cancer-centric pharmaceutical products. In doing so, this business will take the leadership position as the only publicly-listed, China-based pharmaceutical company addressing this important marketplace," said Radient Pharmaceuticals' Chairman and CEO Douglas MacLellan. "Currently JPI is the second leading provider of Domperidone -- an anti-emetic used to prevent nausea and vomiting caused by chemotherapy treatment and other medications, in China. Annual Domperidone sales in this market are estimated to be approximately $250 million at the patient level and approximately $125 million at the wholesale level, with an annual growth rate of approximately 15%. The combined companies will be in a position to gain at least 50% of the Chinese Domperidone market within the next 3 years. Additionally, the companies have other pipeline products that should enable them to introduce a minimum of five additional cancer-centric products, each of which has the potential to generate $50 million in gross revenues by FY2015."
RPC owns approximately 98% of JPI, which is a China-based pharmaceutical company engaged in the manufacture and distribution of generic and homeopathic pharmaceutical products. JPI operates a wholly-owned Chinese subsidiary Jiangxi Jiezhong Bio-Chemical Pharmacy Company Limited (JJB). The closing of the acquisition is subject to customary closing conditions, including shareholder approval and securing satisfactory legal and operational due diligence by both companies; closing is also conditioned upon receipt of any necessary government approvals regarding JPI's ability to acquire the shares at issue. JPI and BaoTai have ninety days to complete due diligence and agree to close the acquisition within the following ninety days, unless both parties mutually agree to extend the closing date for the purposes of receiving required shareholder approval. If the conditions to be satisfied are not fully met in a timely fashion, the acquisition contemplated by the LOI may not occur.
Thanks, i figured that it "favors upward potential", have a good one!
Radar RPC, should have a volume day today!